Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1569888

This article is part of the Research Topic Naturally Occurring Compounds and Their Applications in Endocrinology: Mechanisms, Therapeutic Potential and Clinical Applications View all 3 articles

The antidepressant effects of Kaji-ichigoside F1 via activating PPARγ/CX3CR1/Nrf2 signaling and suppressing NF-κB/NLRP3 signaling pathways

Provisionally accepted
Qiji Li Qiji Li *Maoyang Huang Maoyang Huang Faju Chen Faju Chen Lang Zhou Lang Zhou Qing Zhang Qing Zhang Li Wang Li Wang Liangqun Li Liangqun Li Lishou Yang Lishou Yang Ming Gao Ming Gao Lilang Li Lilang Li Yu Wang Yu Wang Juan Yang Juan Yang Guanping Yao Guanping Yao Xiaosheng Yang Xiaosheng Yang
  • Guizhou Medical University, Guiyang, China

The final, formatted version of the article will be published soon.

    Introduction: Depression is a mental illness closely associated with neurological damage and is characterised by high rates of suicide and mood changes. As a traditional medicinal plant, Rosa roxburghii Tratt has been widely used since ancient times in the Miao and Dong regions of Southwest China for the relief of sleep disorders, indigestion, anti-inflammation, neurasthenia and neuroprotection. The total triterpenes of R. roxburghii were previously found to have certain neuroprotective effects, and whether Kaji-ichigoside F1 (KF1), as its main ingredient, plays a relevant pharmacological role needs to be further investigated. Methods: Establishment of mouse depression model and BV2 microglia inflammation model using intraperitoneal injection of LPS in mice and LPS stimulated-BV2 microglia, respectively. The antidepressant effects of KF1 were evaluated by forced swim test (FST), sucrose preference test (SPT), tail suspension test (TST) and open field test (OFT). The number of Nissl bodies and apoptotic positive cells in the CA1 region of the hippocampus was observed by Nissl and TUNEL staining. Then, the levels of TNF, PPAR-γ, TGF-β, and IL-6 cytokines were tested by ELISA kits. Finally, the molecular mechanisms were investigated by Western blotting (WB) and immunofluorescence in vivo and in vitro.Results: KF1 dramatically ameliorated LPS-induced depressive like behaviors, neuronal damage, apoptosis, and suppressed the levels of pro-inflammatory cytokines in the serum and hippocampus of mice. Our vitro experiment also showed KF1 significantly reduced cell viability and attenuated apoptosis in LPS-induced BV2 microglia, decreased the mean fluorescence intensity of Caspase-1, TNF, NF-B, IL-1β, NLRP3, and Keap1. However, the mean fluorescence intensity of GCLC, GCLM, GST, SOD1, HO-1, and Nrf2 were significantly increased. Finally, western blot analysis showed that KF1 suppressing the expression of NF-κB/NLRP3 signaling pathway and activating PPARγ/CX3CR1/Nrf2 signaling pathway both in vivo and in vitro.In conclusion, these results suggest that KF1 is an effective alleviator of LPS-induced depression-like effects in vivo and in vitro. These effects were associated with activating PPARγ/CX3CR1/Nrf2 signaling, and suppressing NF-κB/NLRP3 signaling pathways.

    Keywords: Kaji-ichigoside F1, Depression, PPAR-γ/CX3CR1/Nrf2, NF-κB/NLRP3, LPS COX2, Cyclooxygenase-2, ESC, Escitalopram, ELISA, enzyme-linked immunosorbent assay, FST, Forced swimming test, Gclc, Glutamate-cysteine ligase catalytic subunit, GCLM, Glutamate-cysteine ligase modifier subunit, HO-1, heme oxygenase-1, IL-6, interleukin-6

    Received: 02 Feb 2025; Accepted: 31 Mar 2025.

    Copyright: © 2025 Li, Huang, Chen, Zhou, Zhang, Wang, Li, Yang, Gao, Li, Wang, Yang, Yao and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Qiji Li, Guizhou Medical University, Guiyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more